We confirmed that the proportion of CD3+ and CD8+ T cells in the peripheral blood of HBV-HCC patients decreased significantly, while the Tregs increased compare with HBV-LC group (p<0.05) (Figures 9A, B). This evidence concerns the gene CD8A and hepatocellular carcinoma.